Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medifast Inc (MED)

Medifast Inc (MED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 119,362
  • Shares Outstanding, K 10,991
  • Annual Sales, $ 602,460 K
  • Annual Income, $ 2,090 K
  • EBIT $ -6 M
  • EBITDA $ 6 M
  • 60-Month Beta 0.48
  • Price/Sales 0.20
  • Price/Cash Flow 3.75
  • Price/Book 0.56

Options Overview Details

View History
  • Implied Volatility 62.00% (+15.22%)
  • Historical Volatility 28.55%
  • IV Percentile 80%
  • IV Rank 54.79%
  • IV High 87.66% on 11/11/25
  • IV Low 30.91% on 12/12/24
  • Expected Move (DTE 13) 0.92 (8.44%)
  • Put/Call Vol Ratio 0.06
  • Today's Volume 649
  • Volume Avg (30-Day) 473
  • Put/Call OI Ratio 0.08
  • Today's Open Interest 26,980
  • Open Int (30-Day) 29,715
  • Expected Range 9.96 to 11.80

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.80
  • Number of Estimates 1
  • High Estimate -0.80
  • Low Estimate -0.80
  • Prior Year 0.10
  • Growth Rate Est. (year over year) -900.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.36 +5.02%
on 11/20/25
12.38 -12.12%
on 11/06/25
-1.30 (-10.67%)
since 11/05/25
3-Month
10.36 +5.02%
on 11/20/25
14.67 -25.84%
on 09/18/25
-2.67 (-19.70%)
since 09/05/25
52-Week
10.36 +5.02%
on 11/20/25
21.98 -50.50%
on 12/11/24
-9.08 (-45.49%)
since 12/05/24

Most Recent Stories

More News
3 Stocks Under $50 We’re Skeptical Of

3 Stocks Under $50 We’re Skeptical Of

HAYW : 16.09 (-0.49%)
LXFR : 12.90 (-0.46%)
MED : 10.88 (+0.18%)
3 of Wall Street’s Favorite Stocks We Keep Off Our Radar

3 of Wall Street’s Favorite Stocks We Keep Off Our Radar

FLWS : 3.50 (+0.29%)
DBI : 4.88 (+4.72%)
MED : 10.88 (+0.18%)
3 Small-Cap Stocks That Fall Short

3 Small-Cap Stocks That Fall Short

MLKN : 15.76 (-1.31%)
NX : 13.85 (+1.39%)
MED : 10.88 (+0.18%)
3 Unprofitable Stocks That Fall Short

3 Unprofitable Stocks That Fall Short

OPAD : 1.8300 (-7.58%)
EL : 105.13 (+1.26%)
MED : 10.88 (+0.18%)
Medifast Scientific & Clinical Affairs Team Showcases New Research in Metabolic Health at ObesityWeek Conference

Company’s Clinical Heritage and Leadership in Metabolic Health Highlighted Through Poster Presentations and Expert Contributions

MED : 10.88 (+0.18%)
5 Insightful Analyst Questions From Medifast’s Q3 Earnings Call

5 Insightful Analyst Questions From Medifast’s Q3 Earnings Call

MED : 10.88 (+0.18%)
MED Q3 Deep Dive: Focus Shifts to Metabolic Health Amid Industry Challenges

MED Q3 Deep Dive: Focus Shifts to Metabolic Health Amid Industry Challenges

MED : 10.88 (+0.18%)
Medifast: Q3 Earnings Snapshot

Medifast: Q3 Earnings Snapshot

MED : 10.88 (+0.18%)
Medifast (NYSE:MED) Posts Q3 Sales In Line With Estimates

Medifast (NYSE:MED) Posts Q3 Sales In Line With Estimates

MED : 10.88 (+0.18%)
Medifast Announces Third Quarter 2025 Financial Results

Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the third quarter ended September 30, 2025. ...

MED : 10.88 (+0.18%)

Business Summary

Medifast is a leading manufacturer and distributor of clinically-proven healthy living products and programs. The company produces, distributes and sells weight loss, weight management and healthy living products throughits direct online channels as well as franchise weight control centers. The company...

See More

Key Turning Points

3rd Resistance Point 11.36
2nd Resistance Point 11.23
1st Resistance Point 11.06
Last Price 10.88
1st Support Level 10.75
2nd Support Level 10.61
3rd Support Level 10.44

See More

52-Week High 21.98
Fibonacci 61.8% 17.54
Fibonacci 50% 16.17
Fibonacci 38.2% 14.80
Last Price 10.88
52-Week Low 10.36

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar